Antolin J, Amerigo MJ, Cantabrana A, Roces A, Jimenez P: Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE.

In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with ...

Uncommon Presentations A higher prevalence of more uncommon manifestations of SLE, such as gastrointestinal ... associating with different clinical courses (mild disease with no major organ ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Correspondence to Dr Dimitrios T Boumpas, Rheumatology and Clinical Immunology Unit ... neuropsychiatric and haematological disease, SLE-associated antiphospholipid syndrome, kidney protection, as ...

Autolus reported Q1 2025 net product sales of $9.0 million. The Company has 39 centers fully activated in the U.S. as of May 7, 2025. Patient access to AUCATZYL continues to increase, with coverage ...

1 Despite a similar pathology, it has been shown in the Achilles that exercise specific for insertional or mid-tendon tendinopathy provides improved clinical outcomes, probably a reflection of the ...

Good Clinical Practice (GCP), the bedrock of ethical and high-quality clinical research, guides operations among sponsor companies, contract research organisations (CROs), investigator sites ...

Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it can be ...

dDivision Provinciale de la Santé, Bukavu, South-Kivu, Democratic Republic of the Congo eDivision Provinciale de la Santé, Igongo, Mai-Ndombe, Democratic Republic of the Congo fInstitut National de ...